Tag: ACST

Finance

Today’s Stocks : Acasti Pharma Inc. (NASDAQ:ACST), OvaScience, Inc. (NASDAQ:OVAS), Jack Henry & Associates Inc. (NASDAQ:JKHY), InvenSense, Inc. (NYSE:INVN), Facebook Inc (NASDAQ:FB)

On Sep 30, Acasti Pharma Inc. (NASDAQ:ACST), announces top-line results for its pharmacokinetic (PK) trial evaluating the bioavailability and safety of CaPre® on healthy individuals taking single and multiple daily oral doses of the Corporation’s new investigational drug candidate composed of a patent-protected highly concentrated novel omega-3 phospholipid for the prevention and treatment of certain cardiometabolic disorders. Acasti Pharma Inc. (NASDAQ:ACST) belongs to Healthcare sector. … Continue reading Today’s Stocks : Acasti Pharma Inc. (NASDAQ:ACST), OvaScience, Inc. (NASDAQ:OVAS), Jack Henry & Associates Inc. (NASDAQ:JKHY), InvenSense, Inc. (NYSE:INVN), Facebook Inc (NASDAQ:FB)

Mark Doerr
Finance

Hot Stock List : United Continental (NYSE:UAL), QUALCOMM (NASDAQ:QCOM), Hertz Global Holdings (NYSE:HTZ), Acasti Pharma (NASDAQ:ACST), AerCap (NYSE:AER)

Research analysts at Barclays increased their price target on shares of United Continental Holdings (NYSE:UAL) from $46.00 to $48.00 in a report released on Monday. The firm currently has an “underweight” rating on the stock. United Continental Holdings, Inc. (NYSE:UAL) belongs to Services sector. Its net profit margin is 1.80% and weekly performance is -5.23%. On last trading day company shares ended up $43.12. United Continental Holdings, … Continue reading Hot Stock List : United Continental (NYSE:UAL), QUALCOMM (NASDAQ:QCOM), Hertz Global Holdings (NYSE:HTZ), Acasti Pharma (NASDAQ:ACST), AerCap (NYSE:AER)

Kevin Long
BioTech

Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) and Enzymotec Ltd (NASDAQ:ENZY) Conclude Final Patent Infringement Settlement

Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) and Acasti Pharma Inc (NASDAQ:ACST), a Neptune subsidiary, Sunday night announced that a final and binding patent infringement settlement and license agreement has been signed with Enzymotec Ltd. and Enzymotec Ltd(NASDAQ:ENZY) that resolves the International Trade Commission’s investigation of infringement of Neptune’s composition of matter patents, related federal court actions initiated by Neptune against Enzymotec and its distributors, and various patent review … Continue reading Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) and Enzymotec Ltd (NASDAQ:ENZY) Conclude Final Patent Infringement Settlement

Chris Lewis